Understanding Whooping Cough (Pertussis): Symptoms, Vaccines, and Prevention in 2025
What Is Whooping Cough (Pertussis)?
Whooping cough, medically referred to as pertussis, is a highly contagious respiratory disease triggered by the bacterium Bordetella pertussis. This bacterial infection predominantly affects infants and children, but it is not exclusive to young individuals. Adults and teenagers can also contract it, especially those who haven't been vaccinated or whose immunity has declined over time. The infection is notorious for its violent coughing fits that can interfere with breathing, making it a serious public health concern.
The Resurgence of Pertussis in 2025
In 2025, the United States has witnessed a concerning increase in whooping cough cases. Several contributing factors have fueled this resurgence, including international travel, declining vaccination rates, and the natural waning of immunity over time. Public health authorities across federal and state levels are intensifying their outreach efforts, urging the population to stay vigilant and to ensure vaccination schedules are up to date. This resurgence is a stark reminder that even once-controlled diseases can return without sustained preventive measures.
Pertussis Transmission and Incubation Period
Pertussis spreads through respiratory droplets expelled when an infected person coughs, sneezes, or talks. This airborne method of transmission makes it highly contagious, particularly in closed or crowded environments. After exposure to the bacteria, it typically takes 7 to 10 days for symptoms to manifest. However, in some cases, the incubation period may extend up to 21 days, making early detection and containment difficult.
Three Stages of Whooping Cough
The progression of whooping cough occurs in three clinical stages, each with distinct characteristics and severity.
Catarrhal Stage (1–2 Weeks)
This initial phase mimics a standard upper respiratory infection. Individuals may experience a runny nose, mild fever, sneezing, and an occasional mild cough. Despite the symptoms being relatively benign, this stage is when the disease is most contagious, often leading to the inadvertent spread of the bacteria.
Paroxysmal Stage (1–6 Weeks)
The paroxysmal phase is the hallmark of pertussis. Patients suffer from intense and uncontrollable coughing fits that are frequently followed by a high-pitched "whooping" sound as they gasp for air. Vomiting, cyanosis (a bluish skin tone due to oxygen deprivation), and sheer exhaustion after coughing are common. In infants, apnea (pauses in breathing) may occur, potentially leading to life-threatening complications.
Convalescent Stage (2–3 Weeks or More)
The final stage involves a slow and gradual recovery. While the frequency and intensity of coughing begin to diminish, a lingering cough may persist for several weeks. This extended duration can significantly disrupt daily life and lead to further complications, particularly in vulnerable individuals.
Pertussis Symptoms in Different Age Groups
Symptoms of whooping cough can vary significantly depending on the patient's age.
In infants under one year, symptoms are often subtle and dangerous. These include apnea, difficulty feeding, and the absence of the typical "whoop" sound. Due to their underdeveloped immune systems, complications in this group are more severe and frequently require hospitalization.
In children aged 1 to 10 years, the disease presents more traditionally, with classic coughing fits followed by the whooping sound. Vomiting after coughing and disrupted sleep are also common.
Among adolescents and adults, pertussis often resembles bronchitis or seasonal allergies. The cough can last for weeks or months, and in severe cases, can lead to rib fractures or hernias due to the violent nature of the fits. Because it is frequently misdiagnosed, these groups often become unwitting sources of infection.
Complications of Pertussis
If left untreated or in cases involving high-risk individuals, pertussis can result in numerous complications. These include secondary bacterial pneumonia, seizures, encephalopathy (a disorder of brain function), weight loss due to prolonged illness, incontinence, and brain damage, especially in infants. Tragically, pertussis can be fatal, with the highest mortality rates seen in babies under six months of age.
Pertussis Cases and Statistics in 2025
Data from the Centers for Disease Control and Prevention (CDC) indicate a notable increase in pertussis cases in early 2025. Outbreaks have been identified in several states, including California, Texas, and multiple regions throughout the Midwest. Analysis reveals a strong link between outbreaks and areas with low immunization rates, underlining the critical role vaccines play in community protection.
Pertussis Diagnosis
Accurate diagnosis is crucial for effective treatment and containment. The primary method is a nasopharyngeal swab followed by PCR testing, which detects bacterial DNA. Although bacterial culture is still used, it is less common due to the time required. In adults, serological testing may help, particularly in late-stage illness. In cases with suspected complications, chest X-rays are used to rule out pneumonia or other issues.
Treatment of Whooping Cough
Antibiotics
Early administration of antibiotics is vital, ideally during the catarrhal stage. Azithromycin is the preferred treatment, but clarithromycin and erythromycin are also effective. Antibiotics can shorten the course of the illness if started early and can also reduce the risk of transmission.
Supportive Care
Supportive care plays a significant role, especially in infants and the elderly. Hydration, nutritional support, and in severe cases, oxygen therapy are essential. Hospitalization may be required for infants with breathing difficulties or feeding challenges.
Vaccination: The Key Preventive Measure
DTaP Vaccine
Administered to children at 2, 4, 6, 15–18 months, and again between 4 and 6 years, the DTaP vaccine provides early and robust protection against diphtheria, tetanus, and pertussis.
Tdap Booster
Adolescents should receive a Tdap booster at 11 or 12 years. Adults who haven’t been vaccinated previously are advised to get one dose. Crucially, pregnant women are urged to receive Tdap during each pregnancy, ideally between weeks 27 and 36, to pass antibodies to their newborns.
Vaccine Effectiveness
The DTaP vaccine is around 85% effective after the full series, and while Tdap provides a necessary immunity boost, its protective effect may wane after a few years. Nonetheless, maintaining herd immunity through widespread vaccination is essential to safeguarding vulnerable groups.
Why Vaccine Hesitancy Is Fueling the 2025 Resurgence
Vaccine hesitancy continues to be a major barrier to disease control. The spread of misinformation on social media platforms, lingering distrust in medical institutions, and philosophical or religious objections contribute to declining vaccination rates. The backlash and skepticism stemming from COVID-19 vaccine debates have further intensified public resistance, leading to reduced community protection.
High-Risk Populations for Severe Disease
Certain groups are more susceptible to severe outcomes from pertussis. These include infants younger than six months, pregnant women, immunocompromised individuals, and elderly adults with chronic health issues. For these populations, prompt diagnosis and prevention are critical.
Public Health Strategies for Outbreak Control
To curb the ongoing outbreaks, public health agencies are employing several key strategies. These include immediate identification and isolation of cases, prophylactic antibiotics for close contacts, intensified vaccination campaigns, and targeted awareness programs in schools and workplaces. These actions are vital for containing spread and preventing further escalation.
Steps to Protect Yourself and Others
Preventing pertussis requires proactive behavior from individuals and communities. Staying up to date with DTaP and Tdap vaccinations is the first line of defense. It is equally important to practice good hygiene—covering coughs and sneezes, washing hands frequently, and avoiding close contact with those showing symptoms. Parents should be particularly cautious about exposing infants to individuals with any respiratory illness.
Long-Term Immunity and Booster Necessity
Immunity from childhood vaccines or natural infection is not permanent. Over time, antibody levels decline, leaving individuals vulnerable again. Booster shots for adolescents and adults are essential to maintaining immunity and ensuring the disease does not spread to those at highest risk, such as newborns.
FAQs on Pertussis
How long is a person contagious?
An infected individual is most contagious during the first 2 to 3 weeks or until five days after beginning antibiotics.
Can vaccinated people still get pertussis?
Yes, though symptoms are generally milder, and they are significantly less likely to spread the disease to others.
Is natural infection lifelong protection?
No. Immunity from natural infection fades over time, similar to vaccine-induced immunity.
What is the death rate in infants?
Infants under two months are at the highest risk, and in severe cases, pertussis can result in fatal complications, such as apnea or pneumonia.
Current CDC Guidelines on Pertussis in 2025
The CDC currently recommends immediate antibiotic treatment upon diagnosis, routine Tdap vaccination for all pregnant women, reinforcement of childhood immunization protocols, and enhanced reporting and surveillance to track emerging clusters effectively.
Conclusion: A Call for Vigilance and Immunization
Whooping cough remains a formidable public health challenge in 2025. Despite being preventable, its resurgence is a warning sign of lapses in immunization and awareness. To protect our communities—especially our youngest and most vulnerable—vaccination must remain a priority. Public education, timely treatment, and unwavering vigilance are the tools that will ultimately help us turn the tide against pertussis.
0 Comments